TY - JOUR
T1 - Clinical practice guidelines for high-resolution breast PET, 2019 edition
AU - Satoh, Yoko
AU - Kawamoto, Masami
AU - Kubota, Kazunori
AU - Murakami, Koji
AU - Hosono, Makoto
AU - Senda, Michio
AU - Sasaki, Masayuki
AU - Momose, Toshimitsu
AU - Ito, Kengo
AU - Okamura, Terue
AU - Oda, Keiichi
AU - Kuge, Yuji
AU - Sakurai, Minoru
AU - Tateishi, Ukihide
AU - Fujibayashi, Yasuhisa
AU - Magata, Yasuhiro
AU - Yoshida, Takeshi
AU - Waki, Atsuo
AU - Kato, Katsuhiko
AU - Hashimoto, Teisuke
AU - Uchiyama, Mayuki
AU - Kinuya, Seigo
AU - Higashi, Tatsuya
AU - Magata, Yasuhiro
AU - Machitori, Akihiro
AU - Maruno, Hirotaka
AU - Minamimoto, Ryogo
AU - Yoshinaga, Keiichiro
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/3
Y1 - 2021/3
N2 - Breast positron emission tomography (PET) has had insurance coverage when performed with conventional whole-body PET in Japan since 2013. Together with whole-body PET, accurate examination of breast cancer and diagnosis of metastatic disease are possible, and are expected to contribute significantly to its treatment planning. To facilitate a safer, smoother, and more appropriate examination, the Japanese Society of Nuclear Medicine published the first edition of practice guidelines for high-resolution breast PET in 2013. Subsequently, new types of breast PET have been developed and their clinical usefulness clarified. Therefore, the guidelines for breast PET were revised in 2019. This article updates readers as to what is new in the second edition. This edition supports two different types of breast PET depending on the placement of the detector: the opposite-type (positron emission mammography; PEM) and the ring-shaped type (dedicated breast PET; dbPET), providing an overview of these scanners and appropriate imaging methods, their clinical applications, and future prospects. The name “dedicated breast PET” from the first edition is widely used to refer to ring-shaped type breast PET. In this edition, “breast PET” has been defined as a term that refers to both opposite- and ring-shaped devices. Up-to-date breast PET practice guidelines would help provide useful information for evidence-based breast imaging.
AB - Breast positron emission tomography (PET) has had insurance coverage when performed with conventional whole-body PET in Japan since 2013. Together with whole-body PET, accurate examination of breast cancer and diagnosis of metastatic disease are possible, and are expected to contribute significantly to its treatment planning. To facilitate a safer, smoother, and more appropriate examination, the Japanese Society of Nuclear Medicine published the first edition of practice guidelines for high-resolution breast PET in 2013. Subsequently, new types of breast PET have been developed and their clinical usefulness clarified. Therefore, the guidelines for breast PET were revised in 2019. This article updates readers as to what is new in the second edition. This edition supports two different types of breast PET depending on the placement of the detector: the opposite-type (positron emission mammography; PEM) and the ring-shaped type (dedicated breast PET; dbPET), providing an overview of these scanners and appropriate imaging methods, their clinical applications, and future prospects. The name “dedicated breast PET” from the first edition is widely used to refer to ring-shaped type breast PET. In this edition, “breast PET” has been defined as a term that refers to both opposite- and ring-shaped devices. Up-to-date breast PET practice guidelines would help provide useful information for evidence-based breast imaging.
KW - Breast PET
KW - FDG
KW - Guidelines
KW - Japanese society of nuclear medicine
KW - Revised edition
UR - http://www.scopus.com/inward/record.url?scp=85099849081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099849081&partnerID=8YFLogxK
U2 - 10.1007/s12149-021-01582-y
DO - 10.1007/s12149-021-01582-y
M3 - Article
C2 - 33492646
AN - SCOPUS:85099849081
SN - 0914-7187
VL - 35
SP - 406
EP - 414
JO - Annals of Nuclear Medicine
JF - Annals of Nuclear Medicine
IS - 3
ER -